WHO ICTRP trial
Receptorial radiotherapy with 177Lu-DOTA-Tyr3-Octreotate as Maintaining Therapy…
EUCTR2010-018333-21-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2010-018333-21-IT |
|---|---|
| Public title | Receptorial radiotherapy with 177Lu-DOTA-Tyr3-Octreotate as Maintaining Therapy in Extended Small Cell Lung Cancer (SCLC) after a first standard chemotherapy line - IRST162.02 |
| Scientific title | Receptorial radiotherapy with 177Lu-DOTA-Tyr3-Octreotate as Maintaining Therapy in Extended Small Cell Lung Cancer (SCLC) after a first standard chemotherapy line - IRST162.02 |
| Primary sponsor | ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | oncological patients MedDRA version: 12.1 Level: LLT Classification code 10026532 Term: Malignant neoplasm of thorax |
| Interventions | Product Name: 177Lu-DOTA-Tyr3-Octreotate Pharmaceutical Form: Solution for infusion INN or Proposed INN: 177LuDOTATATE Concentration unit: mCi millicurie(s) Concentration type: equal Concentration number: 100- |
| Registration date | May 18, 2010 |
| Secondary IDs | IRST162.02 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: